Last reviewed · How we verify

NCT06314321

The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients

Completed NA Last updated 29 March 2024
What this trial tests

NA trial testing Baduanjin exercise in Hemodialysis Complication in 60 participants. Completed in 20 February 2024.

Timeline
1 January 2022
Primary endpoint
30 June 2023
20 February 2024

Quick facts

Lead sponsorAffiliated Hospital of Nantong University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 January 2022
Primary completion30 June 2023
Estimated completion20 February 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Affiliated Hospital of Nantong University

Who can join

Adults 18 to 75, any sex, with Hemodialysis Complication or Shoulder Joint Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the effect of 18-month Baduanjin exercise on shoulder joint function in maintenance hemodialysis (MHD) patients. 60 MHD patients aged 18-75 will included in this study and randomly divided into two groups (intervention group and control group). The intervention group will be led by a professional person and underwent Baduanjin exercise three times a week before hemodialysis. The control group maintained routine treatment and daily activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Baduanjin exercise

Trials testing the same drug.

Other recruiting trials for Hemodialysis Complication

Currently open trials in the same condition.

Other Affiliated Hospital of Nantong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06314321.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing